Ductal Carcinoma In Situ of the Breast contains the most complete discussion of DCIS available in the medical market including biology, detection, diagnosis, pathology, psychology and treatment of the disease.
Contents
History and Epidemiology
- History of Ductal Carcinoma in Situ
- Why Study Ductal Carcinoma in Situ
- The Natural History of Ductal Carcinoma in Situ
- The Epidemiology of Breast Carcinoma in Situ
Biologic Characteristics of Ductal Carcinoma in Situ
- Prognostic Factors in Ductal Carcinoma in Situ
- HER-2/neu Gene Amplificationa dn Overexpression in Ductal Carcinoma in Situ
- New Insights into the Pathogenesis of in Situ Carcinomas of the Breast by Means of Comparative Genomic Hybridization (CGH)
- Model Systems for Ductal Carcinoma in Situ
Detection and Evaluation
- Mammographic Appearances of in Situ Carcinoma
- Ductal Carcinoma in Situ: A Radiological Perspective
- Roles of Breast Magnetic Resonance Imaging for Ductal Carcinoma in Situ
- Ultrasound of Ductal Carcinoma in Situ
Biopsy Techniques
- Mimimally Invasive Biopsy
- Breast Biopsy and Oncoplastic Surgery for the Patient with Ductal Carcinoma in Situ: Surgical, Pathologic, and Radiologic Issues
Pathology
- Practical Pathology of Duct Carcinoma in Situ: How to Derive Optimal Data from the Pathologic Examination
- The Van Nuys Ductal Carcinoma in Situ Classification: An Update
- Angiogenesis in Ductal Carcinoma in Situ of the Breast
- The Local Distribution of Ductal Carcinoma in Situ of the Breast: Whole-Organ Studies
- Large-Section (Macrosection) Histologic Slides
- Predicting Local Recurrence in Patients with Ductal Carcinoma in Situ
- The Diagnostic Reproductibility of Ductal Carcinoma in Situ
Treatment of Ductal Carcinoma In Situ
- Surgical Overview of the Treatment of Ductal Carcinoma in Situ
- Overview of Conservative Surgery and Radiation Therapy Ductal Carcinoma in Situ
- The Lagios Experience
- Treatment of Subclinical Ductal Carcinoma in Situ of the Breast by Local Excision and Serveillance: An Updated Personal Experience
- Ductal Carcinoma in Situ: Experience at Nottingham City Hospital 1973 through 2000
- Ductal Carcinoma in Situ: The Memorial Sloan-Kettering Cancer Center Experience
- The Van Nuys/USC Experience by Treatment
- Ductal Carcinoma in Situ: The Edinburgh Experience
- The Florence Experience
- Bayreuth-Erlangen Experience of "Risk-Adapted" Therapy of Ductal Carcinoma in Situ
- An International Collaborative Study: A 15-Year Experience
- Breast-Conserving Surgery Plus Radiation Therapy in Ductal Carcinoma in Situ: The Institut Curie Experience
- Joint Center for Radiation Therapy Experience
- The Impact of Young Age on Outcome in Patients with Ductal Carcinoma in Situ: The William Beaumont Hospital Experience
- Breast Conserving Therapy for Ductal Carcinoma in Situ: The Van Nuys Experience with Excision Plus Radiation Therapy
- Ductal Carcinoma in Situ: Collected Experience of the French Regional Comprehensive Cancer Centers
- Should All Ductal Carcinoma in Situ Patients Receive Radiation Therapy and Is Partial Breast Irradiation an Option?
- Randomized Trial Overview
- Prospective Clinical Trials: The National Surgical Adjuvant Breast Project Experience
- Prevention of Invasive Breast Cancer in Women with Ductal Carcinoma in Situ: An Update of the National Surgical Adjuvant Breast and Bowel Project Experience
- An Update on European Organization for Research and Treatment of Cancer Trial 10853 for Ductal Carcinoma in Situ of the Breast
- Radiotherapy and Tamoxifen after Complete Excision of Ductal Carcinoma in Situ of the Breast
Tools for Selecting Patients for Breast Conservation with and without Radiation Therapy
- The University of Southern California/Van Nuys Prognostic Index
- Problems with the Use of the Van Nuys Prognostic Index
- Margin Width as the Sole Predictor of Local Recurrence in Patients with Ductal Carcinoma in Situ of the Breast
Adjuvant Therapy, Prevention, and Hormone Replaement Therapy
- Can the New Prevention Strategies Reduce the Incidence of Ductal Carcinoma in Situ?
- Tamoxifen and/or Hormone Replacement Therapy after Treatment for Ductal Carcinoma
- Tamoxifen Chemoprevention for Ductal Carcinoma in Situ: Magic Bullet or Misstep?
Other Issues
- Mastectomy and Immediate Reconstruction for Extensive Ductal Carcinoma in Situ of the Breast
- Ductal Carcinoma in Situ with Microinvasion
- Management of the Contralateral Breast
- Extensive Intraductal Component in Association with Invasive Breast Cancers
- Salvage of Local-Regional Failure
- Outcome after Invasive Local Recurrence in Patients with Ductal Carcinoma in Situ of the Breast
- Axillary Dissection for Ductal Carcinoma in Situ
- The Role of Sentinel Lymph Node Biopsy in Ductal Carcinoma in Situ: The Memorial Sloan-Kettering Opinion
- Explaining Ductal Carcinoma in Situ of the Male Breast
- Interstitial Therapy of Ductal Carcinoma in Situ: Where Does It Stand?
The Ductal Carcinoma in Situ Consensus Conferences
- The European Organization for Research and Treatment of Cancer Ductal Carcinoma in Situ Consensus Meetings
- The Classification and Treatment of Ductal Carcinoma in Situ of the Breast: Summary of the 1997 and 1999 Consensus Conferences
Other Noninvasive Breast Cancers and Preneoplastic Diseases 601
- Breast-Conserving Treatment of Paget's Disease of the Breast with Radiotherapy
- Paget's Disease
- Lobular Carcinoma in Situ
- Pathology of Ductal Carcinoma in Situ: Proliferative and Nonproliferative Benign Breast Disease
Conclusion
Index